Physician profile
Brian A Wiley
NPI 1346490851
$2,204.59
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $975 · 2020: $212 · 2021: $741 · 2022: $159 · 2023: $117.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $117.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $116.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $425.76 | 2019-2021 | |
| Collegium Pharmaceutical, INC. | $322.35 | 2019-2021 | |
| Glaxosmithkline, LLC. | $241.31 | 2022-2023 | Shingrix |
| Biodelivery Sciences International, INC. | $225.47 | 2019-2021 | |
| Medtronic, INC. | $204.38 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $149.53 | 2019-2020 | |
| Arbor Pharmaceuticals, INC. | $134.17 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $94.14 | 2019 | |
| Scilex Pharmaceuticals INC. | $82.82 | 2019-2020 | |
| Medtronic USA, INC. | $82.22 | 2019 | |
| Pfizer INC. | $82.04 | 2019-2021 | |
| Boston Scientific Corporation | $34.69 | 2022 | |
| Daiichi Sankyo INC. | $24.47 | 2019 | |
| Mdd US Operations, LLC | $20.20 | 2020 | |
| Vertical Pharmaceuticals, LLC | $15.86 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $15.60 | 2021 | |
| Pernix Therapeutics Holdings, INC. | $13.33 | 2019 | |
| Tersera Therapeutics LLC | $12.72 | 2019 | |
| Nevro Corp. | $11.78 | 2019 | |
| Radius Health, INC. | $11.75 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Wiley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.